Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-12

FDA Approved: VIGABATRIN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved Actavis Pharma's supplemental application for Vigabatrin, updating the existing approval for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)